Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease

Nature Reviews Drug Discovery 16, 810 (2017). doi:10.1038/nrd.2017.225 Author: Ana L. Mora, Mauricio Rojas, Annie Pardo & Moises Selman Nature Reviews Drug Discovery16, 755–772 (2017)In the original version, navitoclax was incorrectly referred to as an apoptosis inhibitor in Figure 3. The error has been corrected online.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Corrigendum Source Type: research